About Us

Aegle Therapeutics is a clinical stage regenerative medicine company developing novel therapeutics based on its proprietary extracellular vesicle isolation technology. The company is isolating extracellular vesicles secreted by allogeneic bone marrow derived mesenchymal stem cells for the treatment of severe dermatological conditions. Aegle’s EV therapy is initially being developed to treat burns and epidermolysis bullosa, a rare connective tissue disorder, and prevent scarring.

Aegle’s proprietary isolation process is easy to scale, low cost and produces EVs with an extended shelf life.